Sandbox: wdx causes: Difference between revisions

Jump to navigation Jump to search
Line 70: Line 70:
* Post treatment of [[lactic acidosis]] or [[ketoacidosis]]  
* Post treatment of [[lactic acidosis]] or [[ketoacidosis]]  
|-
|-
| colspan="2" |Milk−alkali syndrome
! colspan="2" align="center" style="background:#DCDCDC;" + |Milk−alkali syndrome
| -
| -
| +
| +
Line 96: Line 96:
|
|
|-
|-
| colspan="2" |Transfusion
! colspan="2" align="center" style="background:#DCDCDC;" + |Transfusion
|
|
| +
| +
Line 123: Line 123:
|-
|-
! rowspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" + |Drugs/Medication
! rowspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" + |Drugs/Medication
|Chloruretic diuretics
! align="center" style="background:#DCDCDC;" + |Chloruretic diuretics
|
! align="left" style="background:#DCDCDC;" + |
* Bumetanide
* Bumetanide
* Chlorothiazide
* Chlorothiazide
Line 153: Line 153:
|Contraction alkalosis  
|Contraction alkalosis  
|-
|-
| colspan="2" |Penicillin
! colspan="2" align="center" style="background:#DCDCDC;" + |Penicillin
| +
| +
|
|
Line 179: Line 179:
|
|
|-
|-
| colspan="2" |Licorice  
! colspan="2" align="center" style="background:#DCDCDC;" + |Licorice  
| +
| +
|
|
Line 205: Line 205:
|
|
|-
|-
| colspan="2" |Laxative abuse
! colspan="2" align="center" style="background:#DCDCDC;" + |Laxative abuse
| +
| +
|
|
Line 231: Line 231:
|
|
|-
|-
|Antacids 
! align="center" style="background:#DCDCDC;" + |Antacids 
|
! align="left" style="background:#DCDCDC;" + |
* Aluminum hydroxide
* Aluminum hydroxide
* Sodium polystyrene sulfonate  
* Sodium polystyrene sulfonate  
Line 288: Line 288:
|-
|-
! rowspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gastrointestinal origin
! rowspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gastrointestinal origin
| colspan="2" |Vomiting
! colspan="2" align="center" style="background:#DCDCDC;" + |Vomiting
| +
| +
|
|
Line 314: Line 314:
|
|
|-
|-
| colspan="2" |Nasogastric tube suction
! colspan="2" align="center" style="background:#DCDCDC;" + |Nasogastric tube suction
| +
| +
|
|
Line 340: Line 340:
|
|
|-
|-
| colspan="2" |Zollinger−Ellison syndrome
! colspan="2" align="center" style="background:#DCDCDC;" + |Zollinger−Ellison syndrome
|
|
|
|
Line 366: Line 366:
|
|
|-
|-
| colspan="2" |Bulimia
! colspan="2" align="center" style="background:#DCDCDC;" + |Bulimia
| +
| +
|
|
Line 392: Line 392:
|
|
|-
|-
| colspan="2" |Congenital chloridorrhea
! colspan="2" align="center" style="background:#DCDCDC;" + |Congenital chloridorrhea
| +
| +
|
|
Line 418: Line 418:
|
|
|-
|-
| colspan="2" |Pyloric stenosis
! colspan="2" align="center" style="background:#DCDCDC;" + |Pyloric stenosis
| +
| +
|
|
Line 444: Line 444:
|
|
|-
|-
| colspan="2" |Villous adenoma
! colspan="2" align="center" style="background:#DCDCDC;" + |Villous adenoma
| +
| +
|
|
Line 470: Line 470:
|
|
|-
|-
| colspan="2" |Gastrocystoplasty
! colspan="2" align="center" style="background:#DCDCDC;" + |Gastrocystoplasty
|
|
|
|
Line 524: Line 524:
|-
|-
! rowspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Renal origin
! rowspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Renal origin
| colspan="2" |HTN
! colspan="2" align="center" style="background:#DCDCDC;" + |HTN
|
|
|
|
Line 550: Line 550:
|
|
|-
|-
| colspan="2" |Posthypercapnic state
! colspan="2" align="center" style="background:#DCDCDC;" + |Posthypercapnic state
|
|
|
|
Line 576: Line 576:
|
|
|-
|-
| colspan="2" |Hypomagnesemia
! colspan="2" align="center" style="background:#DCDCDC;" + |Hypomagnesemia
|
|
|
|
Line 602: Line 602:
|
|
|-
|-
| colspan="2" |Hypokalemia
! colspan="2" align="center" style="background:#DCDCDC;" + |Hypokalemia
| +
| +
|
|
Line 628: Line 628:
|
|
|-
|-
| colspan="2" |Bartter's syndrome
! colspan="2" align="center" style="background:#DCDCDC;" + |Bartter's syndrome
| +
| +
|
|
Line 654: Line 654:
|
|
|-
|-
| colspan="2" |Gitelman’s syndrome
! colspan="2" align="center" style="background:#DCDCDC;" + |Gitelman’s syndrome
| +
| +
|
|
Line 680: Line 680:
|
|
|-
|-
| colspan="2" |Renal artery stenosis
! colspan="2" align="center" style="background:#DCDCDC;" + |Renal artery stenosis
|
|
|
|
Line 706: Line 706:
|
|
|-
|-
| colspan="2" |Liddle syndrome
! colspan="2" align="center" style="background:#DCDCDC;" + |Liddle syndrome
|
|
|
|
Line 732: Line 732:
|
|
|-
|-
| colspan="2" |Renal tumors
! colspan="2" align="center" style="background:#DCDCDC;" + |Renal tumors
|
|
|
|
Line 759: Line 759:
|-
|-
! rowspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Endocrine
! rowspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Endocrine
| colspan="2" |Cushing's syndrome
! colspan="2" align="center" style="background:#DCDCDC;" + |Cushing's syndrome
|
|
|
|
Line 785: Line 785:
|
|
|-
|-
| rowspan="2" |Hyperaldosteronism
! rowspan="2" align="center" style="background:#DCDCDC;" + |Hyperaldosteronism
|Primary
! align="center" style="background:#DCDCDC;" + |Primary
|
|
|
|
Line 812: Line 812:
|
|
|-
|-
|Secondary
! align="center" style="background:#DCDCDC;" + |Secondary
|
|
|
|
Line 838: Line 838:
|
|
|-
|-
| rowspan="2" |Adrenal enzyme defects
! rowspan="2" align="center" style="background:#DCDCDC;" + |Adrenal enzyme defects
|11β−Hydroxylase deficiency
!  align="center" style="background:#DCDCDC;" + |11β−Hydroxylase deficiency
|
|
|
|
Line 865: Line 865:
|
|
|-
|-
|17α−Hydroxylase deficiency
!  align="center" style="background:#DCDCDC;" + |17α−Hydroxylase deficiency
|
|
|
|
Line 891: Line 891:
|
|
|-
|-
| colspan="2" |Hypercalcemia/hypoparathyroidism
! colspan="2" align="center" style="background:#DCDCDC;" + |Hypercalcemia/hypoparathyroidism
|
|
|
|
Line 918: Line 918:
|-
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Systemic
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Systemic
| colspan="2" |Cystic fibrosis 
! colspan="2" align="center" style="background:#DCDCDC;" + |Cystic fibrosis 
|
|
|
|

Revision as of 15:09, 17 May 2018

Metabolic Alkalosis

Differential diagnosis of metabolic alkalosis is as follow:[1]

Category Disease Mechanism Clinical Paraclinical Gold standard diagnosis Other findings
Symptoms Signs Lab data
ABG Chemistry Enzyme Renal function
Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl
Exogenous HCO3 loads Acute alkali administration[2] + - + - + Nl
Milk−alkali syndrome - + - + -
Transfusion +
Drugs/Medication Chloruretic diuretics
  • Bumetanide
  • Chlorothiazide
  • Metolazone
+ + + Contraction alkalosis  
Penicillin +
Licorice + +
Laxative abuse +
Antacids 
  • Aluminum hydroxide
  • Sodium polystyrene sulfonate  
+
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
Gastrointestinal origin Vomiting + + +
Nasogastric tube suction + + +
Zollinger−Ellison syndrome
Bulimia + +
Congenital chloridorrhea + +
Pyloric stenosis +
Villous adenoma + +
Gastrocystoplasty +
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
Renal origin HTN
Posthypercapnic state + +
Hypomagnesemia Nl
Hypokalemia + Nl
Bartter's syndrome + + Nl
Gitelman’s syndrome + +
Renal artery stenosis Nl
Liddle syndrome +
Renal tumors
Endocrine Cushing's syndrome Nl
Hyperaldosteronism Primary Nl
Secondary
Adrenal enzyme defects 11β−Hydroxylase deficiency
17α−Hydroxylase deficiency
Hypercalcemia/hypoparathyroidism +
Systemic Cystic fibrosis  +
Category Disease Hydrogen loss Accumulation of base Chloride depletion Mineralocorticoid excess Fever Dyspnea Edema Toxic/ill BP Dehydration HCO3 paCO2 O2 Cl K+ Na+ Ca+ Mg+ Renin Bun Cr Urine Cl Gold standard diagnosis Other findings
  1. Galla JH (February 2000). "Metabolic alkalosis". J. Am. Soc. Nephrol. 11 (2): 369–75. PMID 10665945.
  2. Máttar, João A.; Weil, Max Harry; Shubin, Herbert; Stein, Leon (1974). "Cardiac arrest in the critically III". The American Journal of Medicine. 56 (2): 162–168. doi:10.1016/0002-9343(74)90593-2. ISSN 0002-9343.